Recorded live at the 4th BioCeuticals Research Symposium, Andrew talked with integrative cardiologist Dr Mark Houston about the changes he has witnessed in the management of cardiovascular disease. Dr Houston covers the relevance of patient genetics in understanding the progression of disease, as well as the modifiable risk factors and key methods of assessment based on his clinical experience. This insightful discussion shows there is a paradigm shift emerging in the understanding of cardiovascular disease.
Mark C. Houston, MD, MS, ABAARM, FACP, FAHA, FASH, is associate clinical professor of medicine at Vanderbilt University School of Medicine; director of the Hypertension Institute and Vascular Biology; and medical director of the Division of Human Nutrition at Saint Thomas Medical Group, Saint Thomas Hospital in Nashville, Tennessee. He is also on the faculty of the University of South Florida for the Functional and Metabolic Medicine Fellowship. He specialises in hypertension, lipid disorders, prevention, and treatment of cardiovascular diseases, nutrition, clinical age management and general internal medicine.
OTHER PODCASTS WITH DR MARK HOUSTON INCLUDE:
- Genesis of Disease
- A Revolution in the Treatment and Prevention of Cardiovascular Disease
- Integrative Cardiology: Dyslipidaemia and Hypertension